NEW YORK, April 2 - The Translational Genomics Institute of Phoenix, Ariz., will enter into a research alliance with the Southwest Autism Research and Resource Center, according to news reports.
TGen was created to apply genomic discoveries into treatments for common diseases.
The Southwest Autism center will provide access to patients, families, and doctors for genetic testing and possible treatment, according to an article published today in The Arizona Republic newspaper.
The alliance is the first for Translational Genomics, a public-private collaboration with ties to the University of Arizona, Northern Arizona University and Arizona State University. It is part of an effort by Arizona academic administrators, politicians and business to attract biotechnology research to the state. Jeffrey Trent, former scientific director of the National Human Genome Research Institute, was named president and CEO in June.
TGen is funded with $90 million in public and private funds.